Mystic Holdings, Inc. (MSTH)
OTCMKTS · Delayed Price · Currency is USD
0.0130
0.00 (0.00%)
At close: Aug 21, 2025
Mystic Holdings Revenue
In the year 2024, Mystic Holdings had annual revenue of $21.40M with 24.68% growth. Mystic Holdings had revenue of $11.93M in the half year ending December 31, 2024, with 128.14% growth.
Revenue
21.40M
Revenue Growth
+24.68%
P/S Ratio
0.07
Revenue / Employee
198.11K
Employees
130
Market Cap
1.48M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 21.40M | 4.24M | 24.68% |
| Dec 31, 2023 | 17.16M | 7.10M | 70.65% |
| Dec 31, 2022 | 10.06M | -4.09M | -28.90% |
| Dec 31, 2021 | 14.14M | 764.20K | 5.71% |
| Dec 31, 2020 | 13.38M | 8.92M | 199.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Glass House Brands | 221.55M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Global Cord Blood | 196.10M |